SpaceX Sets $135 Share Price for Record $74.4 Billion IPO

Cover image from engadget.com, which was analyzed for this article
SpaceX filed for an IPO targeting up to $75 billion valuation, the largest ever, with implications for Musk's wealth and tech listings.
PoliticalOS
Thursday, June 4, 2026 — Business
SpaceX’s proposed $1.75 trillion valuation hinges on future AI and space infrastructure revenue that has not yet materialized. Investors must weigh record fundraising potential against the company’s current losses and the historical tendency of high-priced IPOs to decline post-listing. The final share price and trading details will be settled by market demand on or after June 11.
What outlets missed
Neither outlet extracted the precise share count or list of selling shareholders from the filing, leaving dilution effects and insider exits unquantified. The planned 1 million satellite orbital data-center constellation and its sun-synchronous orbit parameters received only passing mention despite representing a core use of proceeds. Revenue-sharing details with Anthropic and the $595 million X ad-revenue decline were reported by one outlet but omitted by the other, obscuring inter-company cash flows.
SpaceX Targets Record Breaking IPO With 1.75 Trillion Dollar Valuation
SpaceX has disclosed plans for an initial public offering that would value the company at 1.75 trillion dollars and raise as much as 74.4 billion dollars, a figure that would eclipse the previous record set by Saudi Aramco in 2019. The company set a proposed share price of 135 dollars in an amended filing with regulators, an unusually specific target announced well ahead of the expected trading start on June 12 on the Nasdaq. If shares sell at or near that level, the offering would instantly place SpaceX among the most valuable public companies while pushing Elon Musk's personal stake, roughly 50 percent, toward 752 billion dollars.
The scale of the proposed transaction stands out even against a backdrop of large technology listings. Data from Dealogic shows that nearly half of companies that have gone public over the past three decades have seen their values decline relative to their offering prices. SpaceX's early price disclosure, which most firms withhold until the day before trading begins, reflects confidence in sustained demand from investors who have already driven private valuations from 1.25 trillion dollars earlier this year. The company builds and operates its own rockets and launch infrastructure, including those supporting its Starlink satellite network, and it has secured significant government contracts that underpin much of its revenue stability.
Musk's resulting wealth would mark a further concentration of resources in a single individual who already controls multiple high-profile enterprises. Analysts note that an outcome at the proposed valuation would exceed the combined proceeds of every U.S. IPO over the prior two years. At the same time, the filing has begun to illuminate the company's client relationships and financial dependencies, including work with entities such as Anthropic. Those details arrive as regulators and policymakers continue to examine how dominant positions in emerging sectors like commercial spaceflight interact with public investment and national priorities.
Market reception remains uncertain. The final price will be confirmed on June 11, and demand could shift before then. Should the shares trade materially lower, the gap between the company's self-assessed worth and actual investor appetite would test assumptions about the durability of private-market enthusiasm for space-related ventures. For now, the filing positions SpaceX to convert years of rapid technical progress and government-backed contracts into one of the largest single transfers of equity value in market history.
You just read Liberal's take. Want to read what actually happened?
More in Business & Economy

SpaceX IPO Draws $150 Billion in Orders, Twice Oversubscribed
SpaceX's planned IPO drew massive institutional interest with orders exceeding $10 billion.

GSK Buys Nuvalent for $10.6 Billion to Strengthen Lung Cancer Pipeline
GSK agreed to buy US cancer drugmaker Nuvalent for $10.6 billion in its largest-ever acquisition.

Tech Stocks Tumble as Iran-Israel Strikes Renew Rate Fears
Major indexes tumbled with tech and AI stocks hit hardest as Iran-Israel clashes and economic worries mounted. Nasdaq futures later showed signs of rebound.
US Labor Market Stagnates as AI Slows Entry-Level Hiring
The labor market faces stagnation with low hiring and firing rates, while AI is reshaping entry-level roles and prompting companies like Goldman Sachs to adjust hiring plans.